Drugs Approved for Bladder Cancer
- Adstiladrin (Nadofaragene Firadenovec-vncg)
- Anktiva (Nogapendekin Alfa Inbakicept-pmln)
- Avelumab
- Balversa (Erdafitinib)
- Bavencio (Avelumab)
- Cisplatin
- Doxorubicin Hydrochloride
- Durvalumab
- Enfortumab Vedotin-ejfv
- Erdafitinib
- Imfinzi (Durvalumab)
- Jelmyto (Mitomycin)
- Keytruda (Pembrolizumab)
- Mitomycin
- Nadofaragene Firadenovec-vncg
- Nivolumab
- Nivolumab and Hyaluronidase-nvhy
- Nogapendekin Alfa Inbakicept-pmln
- Opdivo (Nivolumab)
- Opdivo Qvantig (Nivolumab and Hyaluronidase-nvhy)
- Padcev (Enfortumab Vedotin-ejfv)
- Pemazyre (Pemigatinib)
- Pembrolizumab
- Pemigatinib
- Tepadina (Thiotepa)
- Thiotepa
- Valrubicin
- Valstar (Valrubicin)
Drug Combinations Used in Bladder Cancer